ALGN · Align Technology, Inc.
$178.432026-07-21Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Supplies
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$150
-16.2% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($138 · $191) Analysts Range ($185 · $235) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $3.9B | — | 19.1% | 30.5% | $512MM | −$360MM | $152MM | 11.3% | — | 13.1% | $3.9B | $6.21 | — |
| 2024.Q4 | $3.9B | 0.0% | 19.1% | 30.8% | $509MM | −$307MM | $203MM | 12.3% | — | 13.1% | $3.9B | $6.21 | — |
| 2025.Q1 | $4.0B | 3.5% | 17.4% | 30.7% | $482MM | −$241MM | $241MM | 12.1% | — | 12.2% | $4.0B | $5.88 | — |
| 2025.Q4 | $4.0B | 0.0% | 17.4% | 29.9% | $488MM | −$283MM | $205MM | 12.6% | — | 12.1% | $4.1B | $5.88 | — |
| 2026.Q1 | $4.1B | 2.4% | 16.5% | 27.6% | $490MM | −$223MM | $267MM | 11.8% | — | 11.9% | $4.2B | $6.00 | 18.9 |
| italics below = DCF projection · 10yr Rev CAGR: 4.4% |
| 2027.Q1 | $4.2B | +3.3% | 17.5% | 26.8% | $543MM | −$368MM | $174MM | 10.0% | $158MM | 12.3% | $4.6B | $6.62 | 27.0 |
| 2028.Q1 | $4.4B | +4.6% | 18.2% | 26.1% | $594MM | −$345MM | $249MM | 9.9% | $206MM | 12.5% | $4.9B | $7.25 | 24.6 |
| 2029.Q1 | $4.7B | +5.7% | 19.3% | 25.3% | $676MM | −$329MM | $347MM | 9.8% | $262MM | 13.3% | $5.3B | $8.25 | 21.6 |
| 2030.Q1 | $4.9B | +4.8% | 19.3% | 24.6% | $716MM | −$353MM | $363MM | 9.6% | $249MM | 13.2% | $5.6B | $8.73 | 20.4 |
| 2031.Q1 | $5.1B | +4.5% | 19.3% | 23.8% | $755MM | −$333MM | $422MM | 9.5% | $265MM | 13.1% | $5.9B | $9.22 | 19.4 |
|
| Term. Yr+ | $6.6B | 4.1% | 18.8% | 20.0% | $988MM | −$309MM | $679MM | 8.6% | $6.1B | 13.1% | — | — | — |
Active scenario IV: $150 (-16.2% vs market)